Dianthus Therapeutics, Inc.

DNTH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001690585

SEC filings (opens in a new tab)

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Dianthus Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of DNTH: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	39	76	+37
Shares	10.3M	26.1M	+15.8M (+153.4%)
Value	$106.5M	$782.3M	+$675.7M (+634.5%)

New holders (39)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to DNTH in Q1 2024
Institution	Shares	Value	% of portfolio
Bain Capital Life Sciences Investors, LLC	2,992,028	$89.8M	7.21%
Ra Capital Management, L.P.	2,333,000	$70.0M	0.89%
RTW Investments, LP	666,667	$20.0M	0.30%
Great Point Partners LLC	625,000	$18.8M	2.92%
Janus Henderson Group PLC	375,044	$11.3M	0.01%
Point72 Asset Management, L.P.	352,100	$10.6M	0.03%
Adage Capital Partners GP, L.L.C.	298,000	$8.94M	0.02%
Ally Bridge Group (NY) LLC	216,968	$6.51M	3.62%
Walleye Capital LLC	190,266	$5.71M	0.06%
Goldman Sachs Group Inc	170,217	$5.11M	0.00%
Marshall Wace, LLP	112,930	$3.39M	0.01%
Soleus Capital Management, L.P.	100,000	$3.00M	0.26%
Hudson Bay Capital Management LP	80,000	$2.40M	0.02%
StemPoint Capital LP	43,456	$1.30M	0.35%
Two Sigma Investments, LP	37,971	$1.14M	0.00%
The PNC Financial Services Group, Inc.	37,100	$1.11M	0.00%
HRT Financial LP	34,174	$1.02M	0.01%
Citadel Advisors LLC	24,829	$744.9K	0.00%
Cubist Systematic Strategies, LLC	24,125	$723.8K	0.01%
American Century Companies Inc	21,959	$658.8K	0.00%
Hussman Strategic Advisors, Inc.	21,000	$630.0K	0.15%
State Street Corp	20,398	$611.9K	0.00%
ExodusPoint Capital Management, LP	16,996	$510.0K	0.01%
Marathon Trading Investment Management LLC	14,500	$435.0K	0.17%
Jump Financial, LLC	13,942	$418.3K	0.01%
Squarepoint Ops LLC	13,642	$409.3K	0.00%
Balyasny Asset Management LLC	13,371	$401.1K	0.00%
Virtu Financial LLC	12,995	$390.0K	0.03%
Brevan Howard Capital Management LP	12,253	$367.6K	0.03%
Y-Intercept (Hong Kong) Ltd	12,090	$362.7K	0.03%
Point72 Asia (Singapore) Pte. Ltd.	10,345	$310.4K	0.08%
Bank of New York Mellon Corp	8,426	$252.8K	0.00%
Engineers Gate Manager LP	7,786	$233.6K	0.01%
LMR Partners LLP	7,478	$224.3K	0.01%
XTX Topco Ltd	7,219	$216.6K	0.03%
Polymer Capital Management (HK) LTD	6,686	$200.6K	0.05%
EntryPoint Capital, LLC	363	$10.9K	0.01%
Fernwood Investment Management, LLC	102	$3.06K	0.00%
Macquarie Group Ltd	1,824	$55	0.00%

Sold out (2)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of DNTH in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Nantahala Capital Management, LLC	328,433	$3.42M
ADAR1 Capital Management, LLC	481	$5.00K